Filana Therapeutics, Inc.
FLNA· Nasdaq
FLNAFilana Therapeutics, Inc.
Filed Aug 3, 2023 · 10-Q · 34 days after period end · 0001069530-23-000039
| Metric | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|
| Net Income | -$26.38M | -$19.33M | -$5.13M | -$1.14M |
| EPS Diluted | -$0.63 | -$0.48 | -$0.13 | -$0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Filana Therapeutics, Inc. · CIK 1069530 · Engraved from SEC EDGAR
ended Jun 30, 2023 · filed Aug 3, 2023 · 34 d after period end
